Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Incyte and Merck work together on NSCLC trial; later expanded to include additional cancers

Executive Summary

Incyte Corp. and Merck & Co. Inc. will conduct a Phase I/II trial on a combination of Incyte's INCB24360 with Merck's MK3475 for metastatic and recurrent non-small cell lung cancer and other advanced tumors.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Immuno-Oncology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Alliance
    • Trial Collaborations
    • R&D (No Licensing)

Related Companies